Using both PCOS patient samples in vitro cell and in vivo mouse models, we revealed that excess androgens differentially impact the regulation of steroidogenesis and folliculogenesis in the ovary, with one key regulatory pathway involving AR directly interacting with FOXL2. The gene discussed is FOXL2; the disease is polycystic ovary syndrome.